All In Biotech

Drug Trial Radar · NCT05347095

A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 288 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

288

Actual

Start

Sep 27, 2022

Primary completion

Mar 25, 2027

Study completion Mar 25, 2027

Sponsor

Lead sponsor
Janssen-Cilag Ltd.Johnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Apr 26, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study to evaluate the clinical efficacy of guselkumab in fistulizing, perianal Crohn's disease and to assess the overall safety of guselkumab.

Conditions

  • Fistulizing Crohns Disease
  • Perianal Crohns Disease

Interventions

  • GuselkumabDrug

    Guselkumab will be administered subcutaneously/IV infusion.

  • PlaceboDrug

    Matching placebo will be administered subcutaneously/IV infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants who Achieve Combined Fistula Remission at Week 24Time frame: Week 24

Locations

154 sites in 23 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Yale University

    New Haven, Connecticut

  • University of Miami

    Miami, Florida

  • Gastroenterology Group Of Naples

    Naples, Florida

  • AdventHealth Medical Group Blood & Marrow Transplant at Orlando

    Orlando, Florida

  • Kansas University Medical Center

    Kansas City, Kansas

  • University of Kentucky Chandler Medical Center

    Lexington, Kentucky

  • University of Louisville

    Louisville, Kentucky

  • Washington University School Of Medicine

    St Louis, Missouri

  • Mount Sinai School of Medicine

    New York, New York

  • Digestive Disease Specialists Inc

    Oklahoma City, Oklahoma

  • Gastro One

    Germantown, Tennessee

  • Vanderbilt University Medical Center

    Nashville, Tennessee

  • Tyler Research Institute, LLC

    Tyler, Texas

  • Swedish Medical Center

    Seattle, Washington

  • Flinders Medical Centre

    Adelaide, Australia

  • St Vincent's Hospital - Melbourne

    Fitzroy, Australia

  • Liverpool Hospital

    Liverpool, Australia

  • Fiona Stanley Hospital

    Murdoch, Australia

  • Royal Prince Alfred Hospital

    Newtown, Australia

  • Royal Adelaide Hospital

    North Terrace, Australia

  • Royal Melbourne Hospital

    Parkville, Australia

  • Royal Perth Hospital

    Perth, Australia

  • Mater Hospital

    South Brisbane, Australia

  • Hopital Erasme

    Brussels, Belgium

  • Ziekenhuis Oost-Limburg

    Genk, Belgium

  • UZ Leuven

    Leuven, Belgium

  • CHU Sart Tilman

    Liège, Belgium

  • University of Alberta- Ziedler Ledcor Centre

    Edmonton, Alberta, Canada

  • Nova Scotia Health Authority

    Halifax, Nova Scotia, Canada

  • London Health Sciences Centre

    London, Ontario, Canada

  • Mount Sinai Hospital

    Toronto, Ontario, Canada

  • McGill University Health Centre

    Montreal, Quebec, Canada

  • Nemocnice Ceske Budejovice a s

    České Budějovice, Czechia

  • ISCARE a.s.

    Prague, Czechia

  • Alexandria University Hospital 1

    Alexandria, Egypt

  • Alexandria University Hospital

    Alexandria, Egypt

  • National Hepatology and Tropical Medicine Research Institute

    Cairo, Egypt

  • Ain Shams University Hospital

    Cairo, Egypt

  • Cairo university

    Giza, Egypt

Showing 40 of 154 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.